Home › Funds › Saba Capital Management, L.P. › BMEZ
Saba Capital Management, L.P. position in BMEZ
BLACKROCK HEALTH SCIENCES TE · Financials
Saba Capital Management, L.P. reported holding 1,348,202 shares of BMEZ (BLACKROCK HEALTH SCIENCES TE) in its Q2 2026 13F filing — a position valued at US$20.7M, representing 0.61% of its reported portfolio and ranking #35 among its reported holdings. Saba Capital Management, L.P. has disclosed BMEZ holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Saba Capital Management, L.P.'s BMEZ position evolved
Saba Capital Management, L.P. first disclosed a stake in BMEZ in Q3 2023 at 8,347,664 shares (US$120.3M). The position peaked in Q1 2024 at 20,492,010 shares, worth US$335.9M. Across 9 filings, Saba Capital Management, L.P. increased the stake 4 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 1,348,202 shares valued at US$20.7M — an increase of 588,696 shares quarter over quarter.. Notable position changes include a 101% increase in Q4 2023 (shares rose 12% over the following quarter), a 78% increase in Q2 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 8.35M | $120.29M | New |
| Q4 2023 | 16.79M | $245.93M | Add |
| Q1 2024 | 20.49M | $335.86M | Add |
| Q2 2024 | 20.54M | $315.47M | Hold |
| Q3 2024 | 20.66M | $327.28M | Add |
| Q4 2024 | 20.75M | $298.81M | Hold |
| Q1 2025 | 20.75M | $309.19M | Hold |
| Q1 2026 | 759.51K | $10.91M | New |
| Q2 2026 | 1.35M | $20.69M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BMEZ and 13F data
BMEZ (BLACKROCK HEALTH SCIENCES TE) is a Financials company. 23 other funds we track also report a position in BMEZ — the largest reported positions include RIVERNORTH CAPITAL MANAGEMENT, LLC (US$13.4M), Almitas Capital LLC (US$7.8M), CITY OF LONDON INVESTMENT MANAGEMENT CO LTD (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BMEZ
- RIVERNORTH CAPITAL MANAGEMENT, LLC 873.82K sh · $13.41M · Q2 2026
- Almitas Capital LLC 507.10K sh · $7.78M · Q2 2026
- CITY OF LONDON INVESTMENT MANAGEMENT CO LTD 503.27K sh · $7.73M · Q2 2026
- Atlas Wealth LLC 499.70K sh · $7.67M · Q2 2026
- 1607 Capital Partners, LLC 442.21K sh · $6.79M · Q2 2026
- Z3 Capital Partners, LLC 393.51K sh · $6.04M · Q2 2026
More on Saba Capital Management, L.P.
FAQ
How long has Saba Capital Management, L.P. held BMEZ?
Saba Capital Management, L.P. has disclosed BMEZ holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
What is Saba Capital Management, L.P.'s current position in BMEZ?
As of Q2 2026, Saba Capital Management, L.P. holds 1.35M shares of BMEZ (BLACKROCK HEALTH SCIENCES TE), valued at $20.69M, representing 0.61% of its reported portfolio and ranking #35.
Has Saba Capital Management, L.P. been buying or selling BMEZ?
In the latest 13F filing (Q2 2026), Saba Capital Management, L.P. increased its position in BMEZ. The position peaked in Q1 2024 at 20.49M shares.
Which other funds hold BMEZ?
Other major institutional holders of BMEZ include RIVERNORTH CAPITAL MANAGEMENT, LLC, Almitas Capital LLC, CITY OF LONDON INVESTMENT MANAGEMENT CO LTD, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.